INT MEDICAL (01501) has announced the termination of a subscription agreement previously entered into with Broncus Holding Corporation (Broncus, Stock Code: 2216). The agreement, dated October 10, 2025, involved the subscription of 91,093,600 new shares of Broncus at a price of HK$3.11 per share, for a total consideration of HK$283 million. On May 26, 2026, INT MEDICAL and Broncus executed a termination agreement, under which both parties mutually agreed to terminate the subscription agreement and the transaction contemplated therein. Pursuant to the termination agreement, all obligations and liabilities under the subscription agreement have been fully and irrevocably discharged, except for confidentiality obligations. Neither party has any further claims against the other, also with the exception of confidentiality duties. As of the date of this announcement, INT MEDICAL has not made any payment to Broncus under the subscription agreement.